SA Anabolic. RetaRipped 10 mg (Prefilled Retatrutide Subcataneous Injection Pen 10 mg per PEN)

Retatrutide – Key Properties - Type: Triple agonist (GLP-1, GIP, Glucagon receptors) - Indication: Obesity and metabolic disorders (under clinical trial) - Mechanism: -- GLP-1 → appetite suppression, delayed gastric emptying, improved glycemic control -- GIP → enhances insulin response, supports metabolic balance -- Glucagon → increases energy expenditure, promotes fat loss -Effectiveness (Phase 2 trial data): -- 20% average body weight reduction within 48 weeks (in obese adults without diabetes) - Side effects: -- Nausea, vomiting, diarrhea, GI discomfort (similar to GLP-1 drugs)